-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Gene Therapy for Sickle Cell Disease

Program: Education Program
Session: Improving Outcomes for Individuals With Sickle Cell Disease: Are We Moving the Needle?
Monday, December 11, 2023, 4:30 PM-5:45 PM

John F. Tisdale, MD

Cellular and Molecular Therapeutics Branch, NHLBI/NIDDK, NIH, Bethesda, MD; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

Disclosures: No relevant conflicts of interest to declare.

See more of: Improving Outcomes for Individuals With Sickle Cell Disease: Are We Moving the Needle?
See more of: Education Program
<< Previous Presentation | Next Presentation